Antiemetic Efficacy of Adding Olanzapine 5 mg to Aprepitant, Palonosetron and Dexamethasone-Sparing After Day Two for Cancer Patients Receiving Anthracycline and Cyclophosphamide

PURPOSE: Chemotherapy-induced nausea and vomiting (CINV) decrease patient quality of life (QOL). We evaluated the efficacy of adding 5 mg Olz to a three-drug steroid-sparing antiemetic regimen (aprepitant, palonosetron, and dexamethasone-sparing after day two) for breast cancer (BC) patients receivi...

Descripción completa

Detalles Bibliográficos
Autores principales: Suehiro, Marii, Kojima, Yasuyuki, Takahashi, Masaki, Ito, Yuka, Keira, Takayuki, Ikegawa, Kiwako, Minatogawa, Hiroko, Tsugawa, Koichiro, Tanaka, Tsuneaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898054/
https://www.ncbi.nlm.nih.gov/pubmed/33628052
http://dx.doi.org/10.2147/CMAR.S280995

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898054/
https://www.ncbi.nlm.nih.gov/pubmed/33628052
http://dx.doi.org/10.2147/CMAR.S280995

Ejemplares similares